A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group.
Hall, Jacqueline Anne
A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group. [electronic resource] - The Lancet. Oncology Apr 2014 - e184-93 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1474-5488
10.1016/S1470-2045(13)70607-7 doi
Biomarkers, Tumor--metabolism
Checklist
Clinical Trials as Topic--economics
Consensus
Europe
Humans
National Cancer Institute (U.S.)--economics
Neoplasms--metabolism
Patient Selection
Research Design
Research Support as Topic
Risk Assessment
Risk Factors
Risk Management
Treatment Outcome
United States
A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group. [electronic resource] - The Lancet. Oncology Apr 2014 - e184-93 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1474-5488
10.1016/S1470-2045(13)70607-7 doi
Biomarkers, Tumor--metabolism
Checklist
Clinical Trials as Topic--economics
Consensus
Europe
Humans
National Cancer Institute (U.S.)--economics
Neoplasms--metabolism
Patient Selection
Research Design
Research Support as Topic
Risk Assessment
Risk Factors
Risk Management
Treatment Outcome
United States